An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations

J. Andrew Woods, Justin B. Usery, Timothy Self, Christopher K. Finch

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

OBJECTIVE.:: Chronic obstructive pulmonary disease (COPD) increasingly is a cause of morbidity and mortality in and economic burden on the US healthcare system, and COPD exacerbations continue to be among the top 10 causes of hospitalization in adults. The objective of this study was to evaluate the incidence and potential implications of missed scheduled nebulized bronchodilator therapy in the setting of acute, non-life-threatening COPD exacerbations. MATERIALS AND METHODS.:: This study was a retrospective chart review of all of the patients with a primary diagnosis of severe, non-life-threatening COPD exacerbations admitted from January 2007 to June 2008 at a university-affiliated hospital. Each patient's inhaled bronchodilator treatment regimen, including potential for nebulization to metered-dose inhaler (MDI) with valved holding chamber (VHC) conversion, was assessed. RESULTS.:: A total of 259 patients met inclusion criteria: 235 (90.7%) patients received inhaled bronchodilators by nebulization alone in the treatment of COPD exacerbations; 81.1% of these patients could have used MDI with VHC. Patients missed 24.3% of their scheduled, nebulized bronchodilator doses. CONCLUSIONS.:: Patient care can be improved through the initiation of MDI with VHC, especially considering the number of missed nebulizations that these patients experienced. Development of an inhaled bronchodilator treatment algorithm for COPD exacerbations should be considered to ensure an evidence-bassed medicine approach to these patients.

Original languageEnglish (US)
Pages (from-to)742-745
Number of pages4
JournalSouthern Medical Journal
Volume104
Issue number11
DOIs
StatePublished - Nov 1 2011

Fingerprint

Bronchodilator Agents
Chronic Obstructive Pulmonary Disease
Disease Progression
Inhalation Spacers
Metered Dose Inhalers
Therapeutics
Patient Care
Hospitalization
Economics
Medicine
Morbidity
Delivery of Health Care
Mortality
Incidence

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations. / Woods, J. Andrew; Usery, Justin B.; Self, Timothy; Finch, Christopher K.

In: Southern Medical Journal, Vol. 104, No. 11, 01.11.2011, p. 742-745.

Research output: Contribution to journalArticle

Woods, J. Andrew ; Usery, Justin B. ; Self, Timothy ; Finch, Christopher K. / An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations. In: Southern Medical Journal. 2011 ; Vol. 104, No. 11. pp. 742-745.
@article{3dc8654a42734b4daa7b6e393ee46ef4,
title = "An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations",
abstract = "OBJECTIVE.:: Chronic obstructive pulmonary disease (COPD) increasingly is a cause of morbidity and mortality in and economic burden on the US healthcare system, and COPD exacerbations continue to be among the top 10 causes of hospitalization in adults. The objective of this study was to evaluate the incidence and potential implications of missed scheduled nebulized bronchodilator therapy in the setting of acute, non-life-threatening COPD exacerbations. MATERIALS AND METHODS.:: This study was a retrospective chart review of all of the patients with a primary diagnosis of severe, non-life-threatening COPD exacerbations admitted from January 2007 to June 2008 at a university-affiliated hospital. Each patient's inhaled bronchodilator treatment regimen, including potential for nebulization to metered-dose inhaler (MDI) with valved holding chamber (VHC) conversion, was assessed. RESULTS.:: A total of 259 patients met inclusion criteria: 235 (90.7{\%}) patients received inhaled bronchodilators by nebulization alone in the treatment of COPD exacerbations; 81.1{\%} of these patients could have used MDI with VHC. Patients missed 24.3{\%} of their scheduled, nebulized bronchodilator doses. CONCLUSIONS.:: Patient care can be improved through the initiation of MDI with VHC, especially considering the number of missed nebulizations that these patients experienced. Development of an inhaled bronchodilator treatment algorithm for COPD exacerbations should be considered to ensure an evidence-bassed medicine approach to these patients.",
author = "Woods, {J. Andrew} and Usery, {Justin B.} and Timothy Self and Finch, {Christopher K.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1097/SMJ.0b013e3182334606",
language = "English (US)",
volume = "104",
pages = "742--745",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations

AU - Woods, J. Andrew

AU - Usery, Justin B.

AU - Self, Timothy

AU - Finch, Christopher K.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - OBJECTIVE.:: Chronic obstructive pulmonary disease (COPD) increasingly is a cause of morbidity and mortality in and economic burden on the US healthcare system, and COPD exacerbations continue to be among the top 10 causes of hospitalization in adults. The objective of this study was to evaluate the incidence and potential implications of missed scheduled nebulized bronchodilator therapy in the setting of acute, non-life-threatening COPD exacerbations. MATERIALS AND METHODS.:: This study was a retrospective chart review of all of the patients with a primary diagnosis of severe, non-life-threatening COPD exacerbations admitted from January 2007 to June 2008 at a university-affiliated hospital. Each patient's inhaled bronchodilator treatment regimen, including potential for nebulization to metered-dose inhaler (MDI) with valved holding chamber (VHC) conversion, was assessed. RESULTS.:: A total of 259 patients met inclusion criteria: 235 (90.7%) patients received inhaled bronchodilators by nebulization alone in the treatment of COPD exacerbations; 81.1% of these patients could have used MDI with VHC. Patients missed 24.3% of their scheduled, nebulized bronchodilator doses. CONCLUSIONS.:: Patient care can be improved through the initiation of MDI with VHC, especially considering the number of missed nebulizations that these patients experienced. Development of an inhaled bronchodilator treatment algorithm for COPD exacerbations should be considered to ensure an evidence-bassed medicine approach to these patients.

AB - OBJECTIVE.:: Chronic obstructive pulmonary disease (COPD) increasingly is a cause of morbidity and mortality in and economic burden on the US healthcare system, and COPD exacerbations continue to be among the top 10 causes of hospitalization in adults. The objective of this study was to evaluate the incidence and potential implications of missed scheduled nebulized bronchodilator therapy in the setting of acute, non-life-threatening COPD exacerbations. MATERIALS AND METHODS.:: This study was a retrospective chart review of all of the patients with a primary diagnosis of severe, non-life-threatening COPD exacerbations admitted from January 2007 to June 2008 at a university-affiliated hospital. Each patient's inhaled bronchodilator treatment regimen, including potential for nebulization to metered-dose inhaler (MDI) with valved holding chamber (VHC) conversion, was assessed. RESULTS.:: A total of 259 patients met inclusion criteria: 235 (90.7%) patients received inhaled bronchodilators by nebulization alone in the treatment of COPD exacerbations; 81.1% of these patients could have used MDI with VHC. Patients missed 24.3% of their scheduled, nebulized bronchodilator doses. CONCLUSIONS.:: Patient care can be improved through the initiation of MDI with VHC, especially considering the number of missed nebulizations that these patients experienced. Development of an inhaled bronchodilator treatment algorithm for COPD exacerbations should be considered to ensure an evidence-bassed medicine approach to these patients.

UR - http://www.scopus.com/inward/record.url?scp=80155201187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80155201187&partnerID=8YFLogxK

U2 - 10.1097/SMJ.0b013e3182334606

DO - 10.1097/SMJ.0b013e3182334606

M3 - Article

C2 - 22024782

AN - SCOPUS:80155201187

VL - 104

SP - 742

EP - 745

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 11

ER -